A VC’s take on the Genomic Age
Mohr Davidow Ventures partner Bill Ericson, who helped fund high-speed genome-sequencer Pacific Biosciences, is a big believer in the emerging Age of Genomics and its potential to transform medicine, health insurance and our understanding of ourselves.
Check out my recent Q&A with the venture capitalist… Continue Reading
Q&A with MDV’s Bill Ericson: On PacBio’s origin, why Gattaca isn’t our future, and throwing out your statins
Bill Ericson doesn’t see much cause for pessimism about the dawning Genomic Age. The Mohr Davidow Ventures partner, who’s helped resuscitate the firm’s life-science practice since he came aboard in 2000, believes the widespread dissemination of genetic information will be a virtually unalloyed good, opening… Continue Reading